Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

13.16

-0.30

(-2.25%)

As of 12:26PM EDT. Market open.

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Business Wire
Janux Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
SAN DIEGO, August 09, 2022--Janux Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
- Mannatech Reports Second Quarter End 2022 Financial Results
  Business Wire
- ProntoForms Announces Q2 2022 Financial Results Conference Call
  GlobeNewswire
Simply Wall St.
Further weakness as Janux Therapeutics (NASDAQ:JANX) drops 9.3% this week, taking one-year losses to 54%
Janux Therapeutics, Inc. ( NASDAQ:JANX ) shareholders should be happy to see the share price up 13% in the last month...
Business Wire
Janux Therapeutics to Present at 2022 Jefferies Global Healthcare Conference
SAN DIEGO, June 02, 2022--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced that Janux management will present at the 2022 Jefferies Global Healthcare Conference on Friday, June 10, 2022 at 11:00 a.m. ET in New York, New York.